Cargando…

Efficacy and safety of pulsed radiofrequency combined with pregabalin for herpetic neuralgia: A systematic review and meta-analysis

Pulsed radiofrequency (PRF), as a new technique, is used to treat a variety of chronic pain syndromes, but it has a high recurrence rate for herpetic neuralgia and is often combined with drugs therapy. The aim of this study was to comprehensively evaluate the efficacy and safety of PRF combined with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jun, Lan, Lan, Wang, Wei, Xu, Xinchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256363/
https://www.ncbi.nlm.nih.gov/pubmed/37335664
http://dx.doi.org/10.1097/MD.0000000000033932
_version_ 1785057087698501632
author Chen, Jun
Lan, Lan
Wang, Wei
Xu, Xinchang
author_facet Chen, Jun
Lan, Lan
Wang, Wei
Xu, Xinchang
author_sort Chen, Jun
collection PubMed
description Pulsed radiofrequency (PRF), as a new technique, is used to treat a variety of chronic pain syndromes, but it has a high recurrence rate for herpetic neuralgia and is often combined with drugs therapy. The aim of this study was to comprehensively evaluate the efficacy and safety of PRF combined with pregabalin in the treatment of herpetic neuralgia. METHODS: The electronic databases, including CNKI, Wanfang data, PubMed, Embase, web of science, and Cochrane Library were searched from inception to January 31, 2023. The outcomes were pain scores, sleep quality and side effects. RESULTS: Fifteen studies with 1817 patients were included in this meta-analysis. PRF combined with pregabalin significantly reduced the visual analogue scale/score in patients with postherpetic neuralgia or herpes zoster neuralgia when compared with pregabalin or PRF monotherapy [P < .00001, standardized mean difference (SMD) = −2.01, confidence intervals (CI) = −2.36 to −1.66; P < .00001, SMD = −0.69, CI = −0.77 to −0.61]. Compared with pregabalin monotherapy, PRF combined with pregabalin significantly decreased the pittsburgh sleep quality index score, the dosage and number of days of using pregabalin (P < .00001, SMD = −1.68, CI = −2.19 to −1.17; P < .00001, SMD = −0.94, CI = −1.25 to −0.64; P < .00001, SMD = −1.52, CI = −1.85 to −1.19). However, there was no significant difference in the effect of PRF combined with pregabalin versus PRF alone on pittsburgh sleep quality index score in patients with postherpetic neuralgia (P = .70, SMD = −1.02, CI = −6.11 to 4.07). In addition, PRF combined with pregabalin could significantly decrease the incidence of dizziness, somnolence, ataxia and pain at puncture site when compared with pregabalin monotherapy (P = .0007, odds ratio [OR] = 0.56, CI = 0.40 to 0.78; P = .008, OR = 0.60, CI = 0.41 to 0.88; P = .008, OR = 0.52, CI = 0.32 to 0.84; P = .0007, OR = 12.39, CI = 2.87 to 53.43), but no significant difference was observed when compared with PRF alone. CONCLUSIONS: PRF combined with pregabalin can effectively alleviate the pain intensity and improve sleep quality in patients with herpetic neuralgia, and the incidence of complications was low, so it was worthy of clinical application.
format Online
Article
Text
id pubmed-10256363
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-102563632023-06-10 Efficacy and safety of pulsed radiofrequency combined with pregabalin for herpetic neuralgia: A systematic review and meta-analysis Chen, Jun Lan, Lan Wang, Wei Xu, Xinchang Medicine (Baltimore) 4000 Pulsed radiofrequency (PRF), as a new technique, is used to treat a variety of chronic pain syndromes, but it has a high recurrence rate for herpetic neuralgia and is often combined with drugs therapy. The aim of this study was to comprehensively evaluate the efficacy and safety of PRF combined with pregabalin in the treatment of herpetic neuralgia. METHODS: The electronic databases, including CNKI, Wanfang data, PubMed, Embase, web of science, and Cochrane Library were searched from inception to January 31, 2023. The outcomes were pain scores, sleep quality and side effects. RESULTS: Fifteen studies with 1817 patients were included in this meta-analysis. PRF combined with pregabalin significantly reduced the visual analogue scale/score in patients with postherpetic neuralgia or herpes zoster neuralgia when compared with pregabalin or PRF monotherapy [P < .00001, standardized mean difference (SMD) = −2.01, confidence intervals (CI) = −2.36 to −1.66; P < .00001, SMD = −0.69, CI = −0.77 to −0.61]. Compared with pregabalin monotherapy, PRF combined with pregabalin significantly decreased the pittsburgh sleep quality index score, the dosage and number of days of using pregabalin (P < .00001, SMD = −1.68, CI = −2.19 to −1.17; P < .00001, SMD = −0.94, CI = −1.25 to −0.64; P < .00001, SMD = −1.52, CI = −1.85 to −1.19). However, there was no significant difference in the effect of PRF combined with pregabalin versus PRF alone on pittsburgh sleep quality index score in patients with postherpetic neuralgia (P = .70, SMD = −1.02, CI = −6.11 to 4.07). In addition, PRF combined with pregabalin could significantly decrease the incidence of dizziness, somnolence, ataxia and pain at puncture site when compared with pregabalin monotherapy (P = .0007, odds ratio [OR] = 0.56, CI = 0.40 to 0.78; P = .008, OR = 0.60, CI = 0.41 to 0.88; P = .008, OR = 0.52, CI = 0.32 to 0.84; P = .0007, OR = 12.39, CI = 2.87 to 53.43), but no significant difference was observed when compared with PRF alone. CONCLUSIONS: PRF combined with pregabalin can effectively alleviate the pain intensity and improve sleep quality in patients with herpetic neuralgia, and the incidence of complications was low, so it was worthy of clinical application. Lippincott Williams & Wilkins 2023-06-09 /pmc/articles/PMC10256363/ /pubmed/37335664 http://dx.doi.org/10.1097/MD.0000000000033932 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle 4000
Chen, Jun
Lan, Lan
Wang, Wei
Xu, Xinchang
Efficacy and safety of pulsed radiofrequency combined with pregabalin for herpetic neuralgia: A systematic review and meta-analysis
title Efficacy and safety of pulsed radiofrequency combined with pregabalin for herpetic neuralgia: A systematic review and meta-analysis
title_full Efficacy and safety of pulsed radiofrequency combined with pregabalin for herpetic neuralgia: A systematic review and meta-analysis
title_fullStr Efficacy and safety of pulsed radiofrequency combined with pregabalin for herpetic neuralgia: A systematic review and meta-analysis
title_full_unstemmed Efficacy and safety of pulsed radiofrequency combined with pregabalin for herpetic neuralgia: A systematic review and meta-analysis
title_short Efficacy and safety of pulsed radiofrequency combined with pregabalin for herpetic neuralgia: A systematic review and meta-analysis
title_sort efficacy and safety of pulsed radiofrequency combined with pregabalin for herpetic neuralgia: a systematic review and meta-analysis
topic 4000
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256363/
https://www.ncbi.nlm.nih.gov/pubmed/37335664
http://dx.doi.org/10.1097/MD.0000000000033932
work_keys_str_mv AT chenjun efficacyandsafetyofpulsedradiofrequencycombinedwithpregabalinforherpeticneuralgiaasystematicreviewandmetaanalysis
AT lanlan efficacyandsafetyofpulsedradiofrequencycombinedwithpregabalinforherpeticneuralgiaasystematicreviewandmetaanalysis
AT wangwei efficacyandsafetyofpulsedradiofrequencycombinedwithpregabalinforherpeticneuralgiaasystematicreviewandmetaanalysis
AT xuxinchang efficacyandsafetyofpulsedradiofrequencycombinedwithpregabalinforherpeticneuralgiaasystematicreviewandmetaanalysis